Estimate the per share value of Bristol-Myers Squibb (BMY) common stock using the EV/EBITDA model. The analyst consensus EBITDA forecast for the next fiscal year is $7,507.7 million. Debt is $7,307.0 million and number of shares outstanding is 1,632.2 million. Other necessary information can be obtained from the table shown below

Bristol-Myers Squibb
	Enterprise	Enterprise	Enterprise	Total Debt/
Company	Value/	Value/	Value/	Enterprise
Name	Sales	EBIT	EBITDA	Value
Bristol-Myers Squibb	3.76x	19.17x	16.39x	8.82%
Average	4.96x	20.31x	14.49x	12.47%
Median	4.96x	20.11x	15.23x	11.49%
Pfizer	5.00x	17.80x	12.52x	15.38%
Eli Lilly	4.96x	20.11x	15.71x	10.54%
Merck	4.92x	23.03x	15.23x	11.49%